Company Information

Management Team

President & CEO, OncolysYasuo UrataProfile
Vice President, OncolysYasunari KashiharaProfile
Vice President, OncolysKeiji YoshimuraProfile
Vice President, OncolysNaoki KobayashiProfile
Vice President, OncolysTakashi KamitaniProfile
Outside Board MemberFumio UranoProfile
Corporate AuditorKatsufusa TachiyaProfile
Outside AuditorShiro OhkiProfile
Outside AuditorMichihiro YamaokaProfile
Special AdvisorToshiyoshi FujiwaraProfile
Special AdvisorYasushi RokutandaProfile

Profile of Directors, Auditors and Special Advisors

President & CEOYasuo Urata
Apr.1983:Ono Pharmaceutical Co., Ltd.
Aug.1994:Japan Tobacco Inc.
Mar.2002:Director of R&D Planning Dept., Japan Tobacco Inc.
Aug.2003:Assistant to Director of Pharmaceutical Division, Japan Tobacco Inc.
Mar.2004:Established Oncolys BioPharma Inc., President & CEO (to present)
Nov.2009:Member of Bio Innovation Research Society (Ministry of Economy, Trade and Industry of Japan)
Aug.2016:Board Member, Oncolys USA, Inc.
Vice President, Business DevelopmentYasunari Kashihara
Apr.1991:Ciba-Geigy Japan Ltd. (Novartis Pharma K.K.)
Jan.1997:Santen Pharmaceutical Co., Ltd.
Aug.2002:M.B.A. from Trinity College Dublin, Republic of Ireland
Feb.2005:President & CEO, UMN Pharma Inc.
Mar.2008:Vice President, Oncolys BioPharma Inc. (to present)
Aug.2016:President, Oncolys USA Inc. (to present)
Sep.2016:Board Member, Liquid Biotech USA, Inc.(to present)
Vice PresidentKeiji Yoshimura
Apr.1979:Coopers & Lybrand
Apr.1985:ICI Japan Ltd.
Nov.1993:Director of Finance, Legal & IT Dept., Amgen Japan
Oct.2003:Member of the Board and Senior Executive Officer, Gosen Co., Ltd.
Nov.2007:Member of the Board and CFO, Taiko Paper MFG, Ltd.
Mar.2013:Vice president, Oncolys BioPharma Inc. (to present)
Aug.2016:Board Member, Oncolys USA Inc.(to present)
Vice PresidentNaoki Kobayashi
Apr.1987:Daikyo Incorporated
Dec.1997:Deloitte Tohmatsu Consulting LLC
Oct.1998:Deloitte Touche Tohmatsu LLC
Feb.2001:Executive Officer, Tohmatsu Venture Support Co., Ltd.
Jun.2005:CFO, Argenes Inc.
Feb.2011:Executive Officer, ENAX, INC.
Apr.2012:Executive Officer and CFO, Hatena Co., Ltd.
Aug.2013:Board Member and CFO, Hatena Co., Ltd.
Mar.2017:Adjunct Board Member, Oncolys BioPharma Inc.
Nov.2017:Vice President, Oncolys BioPharma Inc. (to present)
Vice PresidentTakashi Kamitani
Apr.1988:Daiwa Securities Co., Ltd.
Jul.2000:Deputy Manager, PR and IR, Daiwa Securities Group Inc.
Aug.2002:Executive Secretary, Shuwa System Co., Ltd.
Feb.2006:Board Member and CEO, Shuwa System Co., Ltd.
Nov.2006:Vice President and CEO, Shuwa System Co., Ltd.
Jun.2008:President and CEO, Shuwa System Co., Ltd.
Jan.2017:Deputy Director, Operational Control, Oncolys BioPharma Inc. (to present)
Mar.2017:Vice President, Oncolys BioPharma Inc. (to present)
*Mr. Urano is Outside Board Member set forth in Clause 15 Article 2 of Company Act
Outside Board MemberFumio Urano
Apr.1968:Asahi Optical Co., Ltd. (Pentax Corporation)
Jun.1989:Member of the Board, Asahi Optical Co., Ltd.
Jun.2000:President and Representative Director, Asahi Optical Co., Ltd.
Apr.2007:Advisor, Hoya Corporation
Aug.2008:President & CEO, Excalibur Corporation (to present)
Mar.2009:Outside Board Member, TeraRecon, Inc. (United States)
Mar.2013:Outside Board Member, Oncolys BioPharma Inc. (to present)
Feb.2014:Chairman and Representative Director, SESA Co., Ltd. (to present)
Dec.2016:Outside Board Member, UPDRAFTCOM Inc. (to present)
Corporate AuditorKatsufusa Tachiya
Jul.1972:Officer, Ministry of Foreign Affairs of Japan
Aug.1976:Vice Consul, Consulate-General of Japan in Los Angels, USA
Aug.1978:Vice Consul, Consulate-General of Japan in Khorramshahr, Iran
Aug.1980:Hempel A/S, Tokyo office
Aug.1984:Head of Accounting, Japan Computer Vision Ltd.
Dec.1988:Deputy Director, Business Administration, Vorwerk Japan
Apr.1992:Director, Business Administration, Huyck Japan
Sep.2008:Representative Partner, Kei Consulting GK
Jul.2011:Internal Auditor, Oncolys BioPharma Inc.
Sep.2015:Auditor, B-by-C Corporation
Mar.2017:Corporate Auditor, Oncolys BioPharma Inc. (to present)
Outside AuditorShiro Ohki
Apr.1970:Ono Pharmaceutical Co., Ltd.
Jan.1999:Corporate Officer, Director of Clinical Development Dept., Japan Tobacco Inc.
Jun.2004:Advisor, Japan Tobacco Inc.
Sep.2005:Director of Development Dept., Fuji Chemical Industry Co., Ltd.
Mar.2007:Auditor, Oncolys BioPharma Inc. (to present)
Sep.2011:Corporate Advisor, Fuji Chemical Industry Co., Ltd. (to present)
Outside AuditorMichihiro Yamaoka
Apr.1994:Admitted, Japanese Attorney at Law
Apr.2007:Associate Professor, Graduate School of Law, Keio University
Jun.2008:Outside Auditor, Okamoto Machine Tool Works, Ltd. (to present)
Sep.2011:Criminal Law Adviser, The Legal Training and Research Institute of Japan
Jun.2015:Member of National Bar Examination Committee
Mar.2017:Outside Auditor, Oncolys BioPharma Inc. (to present)
Special AdvisorToshiyoshi Fujiwara, M.D., Ph.D.
Sep.1990:M.D., Okayama University
Jan.1991:Engaged in basic research of p53 gene therapy under Dr. Jack A. Roth at the University of Texas MD Anderson Cancer Center (Texas, U.S.A.)
Mar.2004:Member of the Board, Oncolys BioPharma Inc.
Apr.2010:Professor, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University (to present)
Apr.2013:Special Advisor, Oncolys BioPharma Inc. (to present)
Special AdvisorYasushi Rokutanda
Apr.1987:Sumitomo Life Insurance Company
Feb.1992:Venture Link Co., Ltd.
Apr.2000:Member of the Board, Universal Solution Systems, Inc
Mar.2007:Vice President, Oncolys BioPharma Inc.
Apr.2014:Executive Director and Vice President, Oncolys BioPharma Inc.
Mar.2017:Special Advisor, Oncolys BioPharma Inc. (to present)
pagetop